Login / Signup

NAT10 as a potential prognostic biomarker and therapeutic target for HNSCC.

Wenjie TaoGuocai TianShengming XuJiayi LiZhiyuan ZhangJiang Li
Published in: Cancer cell international (2021)
NAT10 could be a potential prognostic marker and a therapeutic target for HNSCC.
Keyphrases
  • human health
  • risk assessment